Patents by Inventor Ronald Mark Evans

Ronald Mark Evans has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nucleic acid encoding gamma retinoic acid receptor fusion protein
    Patent number: 7033828
    Abstract: A novel gamma retinoic acid receptor is disclosed. The novel receptor is encoded for by cDNA carried on plasmid pGEM-hRAR?, which has been deposited with the American Type Culture Collection for patent purposes. Chimeric receptor proteins are also disclosed. The chimera contain at least one functional domain from the new gamma retinoic acid receptor.
    Type: Grant
    Filed: March 1, 2001
    Date of Patent: April 25, 2006
    Assignees: The Salk Institute for Biological Studies, Sloan-Kettering Institute for Caneer Research
    Inventors: Fumimaro Takaku, Takashi Ishikawa, Michio Imawari, Ronald Mark Evans, Kazuhiko Umesono
  • Method of testing compounds for regulation of transcription of peroxisome proliferator activated receptor—gamma
    Patent number: 6830882
    Abstract: In accordance with the present invention, there are provided a class of compounds which are capable of selectively modulating processes mediated by peroxisome proliferator activated receptor-gamma (PPAR-&ggr;). The identification of such compounds makes possible the selective intervention in PPAR-&ggr; mediated pathways, without exerting inadvertent effects on pathways mediated by other PPAR isoforms.
    Type: Grant
    Filed: September 21, 1998
    Date of Patent: December 14, 2004
    Assignee: The Salk Institute for Biological Studies
    Inventors: Ronald Mark Evans, Barry Marc Forman
  • Gamma retinoic acid receptor
    Publication number: 20040171800
    Abstract: A novel gamma retinoic acid receptor is disclosed. The novel receptor is encoded for by cDNA carried on plasmid pGEM-hRAR&ggr;, which has been deposited with the American Type Culture Collection for patent purposes. Chimeric receptor proteins are also disclosed. The chimera contain at least one functional domain from the new gamma retinoic acid receptor.
    Type: Application
    Filed: March 1, 2001
    Publication date: September 2, 2004
    Applicants: THE SALK INSTITUTE FOR BIOLOGICAL STUDIES, SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH
    Inventors: Fumimaro Takaku, Takashi Ishikawa, Michio Imawari, Ronald Mark Evans, Kazuhiko Umesono
  • Gamma retinoic acid receptor
    Publication number: 20020077457
    Abstract: A novel gamma retinoic acid receptor is disclosed. The novel receptor is encoded for by cDNA carried on plasmid pGEM-hRAR&ggr;, which has been deposited with the American Type Culture Collection for patent purposes. Chimeric receptor proteins are also disclosed. The chimera contain at least one functional domain from the new gamma retinoic acid receptor.
    Type: Application
    Filed: March 1, 2001
    Publication date: June 20, 2002
    Applicant: THE SALK INSTITUTE FOR BIOLOGICAL STUDIES
    Inventors: Fumimaro Takaku, Takashi Ishikawa, Michio Imawari, Ronald Mark Evans, Kazuhiko Umesono
  • Gamma retinoic acid receptor
    Patent number: 6284870
    Abstract: A novel gamma retinoic acid receptor is disclosed. The novel receptor is encoded for by cDNA carried on plasmid pGEM-hRAR&ggr;, which has been deposited with the American Type Culture Collection for patent purposes. Chimeric receptor proteins are also disclosed. The chimera contain at least one functional domain from the new gamma retinoic acid receptor.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: September 4, 2001
    Assignees: The Salk Institute for Biological Studies, Sloan-Kettering Institute for Cancer Research
    Inventors: Fumimaro Takaku, Takashi Ishikawa, Michio Imawari, Ronald Mark Evans, Kazuhiko Umesono